Clinical Trial 46931

Sherman Oaks, CA 91403


Summary:

Randomized study to evaluate the efficacy and safety of AUR101 in patients with moderate-to-severe psoriasis.

8 visits in a 14 week stand.



Criteria:

1. Confirmed diagnosis of chronic plaque-type psoriasis, diagnosed at least 6 months
before screening
2. Psoriasis of at least moderate severity, defined as PASI≥12 and involved BSA≥10
% at screening and Day 1
3. Static 5-point IGA modified [mod] 2011 scale of 3 or higher at screening and Day
1
4. Adult males or females, ≥ 18 to ≤ 70 years of age
5. Ability to communicate well with the investigator and to comply with the
requirements of the entire study
6. Willingness to give written informed consent (prior to any study related
procedures being performed) and ability to adhere to the study restrictions and
assessments schedule


Qualified Participants May Receive:

If you qualify, you can receive all the drugs related to the study at no cost and can be compensated for your time and travel. No insurance needed

Screening Visit $75.00
Visit 2 $75.00
Visit 3 $75.00
Visit 4 $200.00
Visit 5 $75.00
Visit 6 $75.00
Visit 7 $75.00
Visit 8 $75.00


Available At:

Unison Clinical Trials
4955 Van Nuys Blvd Suite 200
Sherman Oaks, CA 91403
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.